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Proteasomal degradationGlycoprotein synthesis is initiated in the endoplasmic reticulum (ER) lumen upon transfer of a
glycan (Glc3Man9GlcNAc2) from a lipid derivative to Asn residues (N-glycosylation).
N-Glycan-dependent quality control of glycoprotein folding in the ER prevents exit to Golgi of fold-
ing intermediates, irreparably misfolded glycoproteins and incompletely assembled multimeric
complexes. It also enhances folding efﬁciency by preventing aggregation and facilitating formation
of proper disulﬁde bonds. The control mechanism essentially involves four components, resident
lectin-chaperones (calnexin and calreticulin) that recognize monoglucosylated polymannose
protein-linked glycans, lectin-associated oxidoreductase acting on monoglucosylated glycoproteins
(ERp57), a glucosyltransferase that creates monoglucosylated epitopes in protein-linked glycans
(UGGT) and a glucosidase (GII) that removes the glucose units added by UGGT. This last enzyme is
the only mechanism component sensing glycoprotein conformations as it creates monoglucosylated
glycans exclusively in not properly folded glycoproteins or in not completely assembled multimeric
glycoprotein complexes. Glycoproteins that fail to properly fold are eventually driven to proteaso-
mal degradation in the cytosol following the ER-associated degradation pathway, in which the
extent of N-glycan demannosylation by ER mannosidases play a relevant role in the identiﬁcation
of irreparably misfolded glycoproteins.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction – the ER as the initial site of protein secretion
Nearly one third of eukaryotic proteins belong to the secretory
pathway, representing about 8000 proteins in humans. Most of
them are synthetized by ribosomes attached to the endoplasmic
reticulum (ER) and enter into the ER through the Sec61 abc
translocon complex. Alternatively, some proteins may enter
post-translationally. This pathway is more frequently employed
in yeast [1]. Secretory pathway proteins fold and assemble in the
ER before continuing their journey. Topologically equivalent to
the cell exterior, the lumen of the ER is a highly crowded environ-
ment, with an oxidizing potential and high calcium concentration,
which ranges in the order of millimolar. For this reason, secretory
pathway proteins face unique challenges in order to fold properly
in this potentially hostile environment. The ER molecular chaper-
ones belong to protein families commonly found in other locations,
such as HSP70 (BiP in the ER) and HSP90 (GRP94 in the ER), but
lacks chaperonine-like proteins. This absence can be partially com-
pensated by GRP94 which, by recognizing advanced folding inter-
mediate, collaborates with BiP in assisting the folding pathway ofselected substrates [2]. Concomitantly with their folding, most
secretory pathway proteins acquire disulﬁde bridges and are
N-glycosylated in the ER. Compared with proteins in other loca-
tions, secretory pathway proteins have a higher frequency of disul-
ﬁde bonds, which stabilize their tertiary structure and oligomer
association. A varied group of protein disulﬁde isomerases (PDIs),
unique to the ER, guarantee the ﬁdelity of the oxidation process.
Equally important, the presence of N-glycans allows the operation
of specialized mechanisms that assist the protein folding.2. N-glycosylation
Approximately one quarter of the eukaryotic proteins are
N-glycosylated at the lateral chain of Asn residues displayed within
the consensus sequence Asn-Xxx-Ser/Thr, where Xxx cannot be Pro
(in some cases Asn-Xxx-Cys, Asn-Gly or Asn-Xxx-Val sequences
can also be used) [3]. This motif, named N-glycosylation sequon,
is quite common, with a frequency of about 4–10 sequons every
1000 residues [4].
In most organisms the glycan Glc3Man9GlcNAc2 (G3M9)
(Figs. 1A, B and 2) is initially transferred en bloc from a dolichol-pyr
ophosphate-oligosaccharide, while some protozoans transfer a
shorter version. For instance, Trypanosome cruzi uses an
AB
Fig. 1. (A) Processing and recognition of N-glycans in the early secretory pathway. (B) Structure of the Glc3Man9GlcNAc2 glycan transferred by the oligosaccharyltransferase.
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The homogeneity of the N-glycan transferred among different spe-
cies is in sharp contrast with the enormous variability of N-glycans
displayed by mature glycoproteins at their ﬁnal destinations. This
diversity is acquired through the action of several glycosidases
and glycosyltransferases located partially in the ER but mainly in
the Golgi apparatus, following a complex and non-linear process.
In mature complex glycoproteins the core glycan Man3GlcNAc2
(M3) is usually the only remnant of the transferred glycan. This
observation points to the dual biological functions of N-glycans
[6]. On one hand, the great variety of glycosidic linkages and
monosaccharide units makes N-glycans perfectly suited to play a
central role in many molecular recognition events at the cell sur-
face. A diverse array of biological processes are modulated or medi-
ated by N-glycans, such as differentiation, migration and
proliferation. On the other hand, early high mannose N-glycans
assist to the protein folding process of several glycoproteins. Due
to their bulky and hydrophilic nature, N-glycans can be considered
as covalently attached chemical chaperones. They prevent protein
aggregation by hindering hydrophobic aggregation-prone regions,
acting as a kind of hydrophilic shield. They can also facilitate the
acquisition of secondary structure elements such as turns [7]. In
addition, N-glycans are used as a ‘‘bar code’’ to display information
regarding the folding status and age of glycoproteins. This code is
generated and interpreted by several glycosidases, glycosyltrans-
ferases and lectins operating in the early secretory pathway.
In brief, monoglucosylated N-glycans are a signature of
glycoproteins displaying immature conformations, while progres-
sive loss of mannose residues marks slowing folding or terminally
misfolded proteins, eventually leading them to degradation. Theseintertwined processes, protein folding quality control (QC) and
endoplasmic reticulum associated degradation (ERAD), are dis-
cussed in the following sections and are schematically outlined
in Figs. 1A and 2).
3. The ER glucosidases
The two outermost glucose residues of the initially transferred
glycan G3M9 are rapidly removed by the sequential action of glu-
cosidase I (GI) and glucosidase II (GII), thus generating the
monoglucosylated intermediate Glc1Man9GlcNAc2 (G1M9). This
glycan is recognized by ER resident lectins calreticulin (CRT),
which is a soluble protein and its type I integral membrane par-
alogue calnexin (CNX), that retain the glycoproteins in the ER
until GII cleaves the last glucose residue. At this point, properly
folded proteins leave the ER toward their ﬁnal destination. By
contrast, those proteins unable to attain a native conformation
or incompletely assembled complexes are recognized by the
enzyme UDP-glucose:glycoprotein glucosyltransferase (UGGT)
that adds the last glucose removed by GII exclusively to glyco-
proteins not displaying their native conformations, thus
re-creating the G1M9 structure. This process allows the
re-association of glycoproteins and CRT/CNX. Cycles of deglucosy-
lation by GII and reglucosylation by UGGT continue until the gly-
coprotein folds properly, that is, when they are no longer
recognized by the last enzyme [8]. Alternatively, proteins unable
to fold properly are eventually directed to degradation by the
ERAD machinery [9].
The a1,2-exoglucosidase GI is a type II membrane protein with
a short cytosolic tail that belongs to the glycosylhydrolase 63
CNX FOLDING
Ub
Dol P P G3M9
EDEM3
QCVs ERQC
ERdj5EDEM1
2
5
3
4
ER
mRNA
OST
GI
GII
ERp57 ERp57
CNX
FOLDING
EDEM2
ER ManI
ER ManI ER ManI ER ManI
BiP
OS9OS9
PROTEASOME
P97
N glycanase
1
GOLGI
GII
6
10E
R
A
D
7 8
9
UGGT
SEC61
folded protein
misfolded protein
ubiquin
Fig. 2. Glycoprotein processing in the early secretory pathway. (1) G3M9 transfer to nascent proteins by the oligosaccharyltransferase complex (OST). (2) After trimming by
glucosidase I (GI), (3) N-glycans are further processed by the heterodimeric glucosidase II (GIIa-GIIb) to generate the monoglucosylated intermediates that are bound by the
ER lectins calnexin (CNX) or calreticulin (not shown). These lectins retain the monoglucosylated intermediates in the ER, preventing their aggregation and facilitating their
folding through the activity of the associated enzymes Erp57 and CypB (not shown). (4) Eventually, GII cleaves the remaining glucose residue. At this point properly folded
species can leave de ER, while misfolded species are recognized by the folding sensor UDP-Glc:glycoprotein glycosyltransferase (UGGT). (5) High mannose glycoproteins leave
the ER to the Golgi by bulk ﬂow or associated with sorting receptors. (6) Mannose trimming initiates in the ER by cleavage of the mannose residue at branch B by EDEM-2 and
ER a1,2-mannosidase I (ER ManI). (7) Further mannose trimming takes place in the ER or in the specialized quality control vesicles (QCVs) or ER quality control (ERQC)
subcompartments. This process is mainly in charge of ER ManI and EDEMs 1 and 3. EDEM 1 associates with the PDI J-domain containing protein ERdj5, which reduces the
disulﬁde bridges of misfolded species. (8) Uncovering of the a1,6-Man residue allows the interaction of the M6 and M5 glycans with the lectin OS-9 and XTP3-B (not shown),
and (9) in conjunction with BiP deliver them to the ERAD retrotranslocation and ubiquitination machinery.
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ensuring the removal of the outermost glucose almost immedi-
ately after transfer of the N-glycan [10]. The a1,3-exoglucosidase
GII is an ER-resident soluble heterodimer composed by a catalytic
subunit (GIIa) non-covalently bound to the GIIb subunit [11–13].
GIIa displays the (G/F)(L/I/V/M)WXDMNE consensus sequence
typical of glycosylhydrolase family 31. GIIa is retained in the ER
through its association to GIIb that has a KDEL-like ER reten-
tion/retrieval signal. GIIb has a mannose receptor homolog
(MRH) domain, which works as a lectin for high mannose glycans
[14]. This domain presents the substrates to the GIIa subunit, thus
dramatically increasing its activity toward high mannose
N-glycans [15–17]. Interestingly, MRH domains also appear in
other lectins of the secretory pathway as both the
cation-dependent and independent Golgi receptors for lysosomal
glycoprotein enzymes and in lectins involved in ERAD (see below),
although with different speciﬁcities. Both in vitro and in vivo exper-
iments showed that the activity of GII decreases as the mannose
content on N-glycan arms B and C (Fig. 1A and B) decreases. The
main residue inﬂuencing GII activity is the outermost residue in
arm C (residue k, Fig. 1B). The molecular basis of this trend should
be interpreted with precaution, since GII is inhibited differently by
its end products. For instance, the decreased activity toward
G1M7BC may reﬂect the greater inhibitory power of M7BC [18].
Regarding the relative speed of both glucose cleavages, current evi-
dence suggest that the ﬁrst cleavage is faster than the second
[16,19], although this difference is not observed in vitro in thepresence of crowding agents [20]. A slower cleavage of the second
glucose would provide a better chance for glycoproteins to enter
the CNX/CRT cycle, although this is matter of debate.
Interestingly, GI and GII are potential targets for antiviral therapies
against several viruses that depend strongly on the CNX/CRT cycle
to mature [21].4. The lectins (CNX and CRT)
CRT (about 400 residues, 46kDa) and CNX (about 572 residues,
65kDa) expression is induced by several types of stress such as heat
shock, heavy metals, amino acid deprivation and calcium-
mobilizing agents. CRT is a multifunctional protein found in several
locations (ER lumen, cytosol, nucleus, secretory granules and plasma
membrane). It has a central role in glycoprotein folding and calcium
homeostasis, but it has also been implicated in trafﬁcking of nuclear
receptors, mRNA stability, complement activation and angiogenesis
[22,23]. CRT and CNX display about 45% sequence similarity, with a
similar domain organization and structure. Both proteins have an
N-terminal signal peptide and share a b-sandwich N-terminal domain
similar to that of leguminous lectins, which is responsible for the lec-
tin activity, followed by a Pro-rich domain (P-domain) and an acidic
C-terminal domain. An intervening transmembrane segment appears
in CNX before the C-terminal domain, which faces the cytosolic side.
CRT is retained in the ER through a KDEL-like C-terminal signal, while
CNXdisplays an RKPRRE ER-localization signal on its cytosolic tail. The
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four copies of motif 1 (IxDP(D/E)(A/D)xKP(D/E)DWD(D/E)) followed
by four copies of motif 2 (GxWxxPxIxNPxY) in a 11112222 pattern.
These motifs are arranged in four modules with a head to tail disposi-
tion. The P-domain of CRT is shorter, having three copies of similar
motifs. The P-domain of CNX protrudes about 140 Å from the globular
domain. It is very ﬂexible, embracing bound glycoproteins and pre-
venting their aggregation. Glycan recognition by these lectins is
strictly dependent on the glucose residue, while additional mannoses
also contribute to the binding energy (Kb = 2.2 104 M1,
56 104 M1 and 102 104 M1 for Glca1,3-Man, Glca1–3Man
a1,2-Man and Glca1,3-Mana1–2Mana1,2-Man, respectively) [24].
The equatorially oriented 2-hydroxyl group of the glucose is necessary
for binding, since 2-deoxyGlca1,2-Man does not bind to CRT.
Interestingly, glycan binging to CRT is enhanced in the presence of
crowding agents, suggesting a stronger interaction in vivowith its cli-
ent proteins [25]. Even though CRT and CNX glycan binding proﬁles
are identical, they bind in vivo to a partially overlapping set of glyco-
proteins, the former protein preferentially associating to glycans
located distally to the ER inner membrane and the latter binding to
glycans close to it [26,27]. Glycoprotein binding to CNX or CRT can
take place cotranslationally. A competition between BiP and
CRT/CNX regulates the initial selection of chaperones, where
N-glycosylation sequons located near theN-terminus of the substrates
favors the interaction with the lectins [28]. In general, BiP and
CRT/CNX cooperate to assist in the complete folding pathway of glyco-
proteins, where early folding intermediates bind to BiP and more
advanced intermediates are bound by the lectins [29–31].
Interestingly, by delaying the oxidation of some key cysteine residues,
early interaction with CNX ensures the proper disulﬁde bond forma-
tion of inﬂuenza membrane glycoproteins hemagglutinin and neu-
raminidase [32,33]. Of note, some microorganisms only have one of
these lectins. For instance, trypanosomatid protozoa only have CRT,
while Saccharomyces cerevisiae and Schizosaccharomyces pombe gen-
omes only code for CNX. Interestingly, CRT and CNX can also interact
through polypeptide-based contacts, similarly to conventional chap-
erones [34]. Indeed, the crystal structure of the globular domain of
CRT revealed a putative peptide binding site located at the edge of
the lectin site [35]. This ability is modulated in CNX by environmental
stressors, such as calcium depletion or high temperature [36]. In vitro
studies have shown that CRT can interact with glycosylated and
non-glycosylated substrates with similar afﬁnities but with different
kinetics, and the conformation displayed by the P-domain depends
on the nature of the bound substrate [37].
CRT is also one of the main calcium buffers in the ER, accounting
for about half of the calcium content in the organelle. This activity
is located in the acidic C-terminal domain of the protein, which can
bind about 25 calcium ions with low afﬁnity (Kd about 1 mM). The
lectin and calcium buffering activities of CRT are mutually inde-
pendent [38]. The C-terminal domain has natively unfolded struc-
ture, and upon calcium binding it adopts a more rigid and compact
conformation [39] and increments its solvent exposition in the full
length protein [40]. Interestingly, this domain seems to regulate
the cellular localization of CRT [41], and upon depletion of ER cal-
cium it could promote the partial retrotranslocation of CRT into the
cytosol [42]. The presence of CRT in the cytosol and its biological
relevance is a matter of debate. Cytosolic CRT can be arginylated
at the N-terminal end after the signal peptide cleavage [43] and
it has been recently shown that this modiﬁcation increases the
half-life of the protein [44]. Since the arginylation machinery is
located in the cytosol, the discovery of arginylated CRT lacking
its signal peptide is a good evidence of its alternative cytosolic
localization. Cytosolic CRT may participate in many functions, such
as regulation of nuclear hormone receptors localization [45] and
mRNA stability [46]. CRT KO in mice is embryonically lethal at
E14.5 as a consequence of an impaired cardiac development [47].This effect can be prevented by expressing a constitutively active
calcineurin in the heart [48], thus showing that CNX can compen-
sate the absence of CRT in the QC system and pointing to an impor-
tant role of CRT in regulating the cellular calcium homeostasis. A
reciprocal situation occurs with CNX. Contrary to early reports
[49], it was shown that CNX KO mice are viable [50]. These animals
display a dysmyelination phenotype in the peripheral and central
nervous systems, but their immune system is not affected, they
are fertile and they have a normal lifespan.
5. The interaction of lectins and glycoproteins
Glycoprotein-CNX/CRT association results in increased folding
efﬁciency, decreased aggregation and facilitation of disulﬁde
bridge isomerization. This last effect is mediated by the activity
of ERp57, a member of the PDI family. The domain architecture
ERp57 (also known as PDIA3) is similar to PDI. Both proteins are
composed of four thioredoxin domains (a, b, b0 and a0), where
domains a and a0 display the redox active motif CGHC. While the
b0 domain of PDI has a hydrophobic patch involved in client protein
binding, a cluster of positively residues in the b0 domain of ERp57
mediates its interaction with the negatively charged tip of the
CRT/CNX P-domain, which in turn presents most known substrates
to ERp57 [51,52]. The interaction between CNX and ERp57 is mod-
ulated by a conserved disulﬁde bridge located at the P-domain,
which is absent in CRT [53]. Deletion of this disulﬁde bridge leads
to a 5-fold increase in the binding constant. The moderate afﬁnities
between CRT/CNX and ERp57 (Kd about 7 lM and 6 lM for CRT
and CNX, respectively) and its fast off-rate (Koff > 1000 s-1) may
imply that ERp57 can rapidly assist several glycoprotein-lectin
complexes. In addition, the ﬂexibility of the P-domain probably
allows ERp57 to scan for disulﬁde bridges at distant positions.
Heavily glycosylated and disulﬁde bond-rich substrates, such as
low density lipoprotein receptor (LDLR), rely on this interaction
for efﬁcient folding and trafﬁcking.
The tip of the P-domain also serves as a platform for interaction
with cyclophilin B (CypB), an ER member of the peptidyl prolyl cis–
trans-isomerase family, thus expanding the capabilities fulﬁlled by
the CRT/CNX cycle. A patch of positively charged residues in CypB
mediates this interaction, with a dissociation constant of about
10 lM [54]. By presenting the substrates to CypB, the interaction
with CNX may improve the intrinsic low catalytic efﬁciency of
the isomerase. Both CypB and ERp57 are very abundant proteins
and the factors regulating the balance between ERp57-CRT/CNX
and CypB-CRT/CNX complexes are unknown.
In addition, the TM domain of CNX displays one or two
conserved CYS residue near the cytosolic side. Under non-stress
conditions, palmitoylation of these residues directs CNX to the
mitochondria-associated membrane (MAM) and facilitates its
interaction with the sarcoendoplasmic reticulum calcium trans-
port ATPase (SERCA) 2b [55]. This interaction modulates the ER
Ca2+ content and the ER–mitochondria Ca2+ crosstalk. Upon ER
stress, CNX is less palmitoylated and migrates from MAM to the
ER and the pericentriolar ER-derived control compartment
(ERQC) where it associates with ERp57 (and likely CypB), thus
focusing its activity in glycoprotein folding. This exempliﬁes the
dynamic nature of the ER, which can adapt and re localize its com-
ponent according to the particular demands of the cell.
Interestingly, the cytosolic domain of CNX has been recently
shown to upregulate the activity of the transcription factor
STAT3 [56]. Treatment with epidermal growth factor induces the
release of this domain by caspase 8, which in turn inhibits the
activity of PIAS3, an inhibitor of STAT3. This pathway depends on
the palmitoylation of CNX, and it is inhibited under ER stress
conditions, thus providing a potential link between ER stress and
cell proliferation.
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Many proteins only need one round of association with
CRT/CNX in order to attain their native conformations [57]. This
is particularly true for those few organisms that lack UGGT such
as S. cerevisiae. Alternatively, glycoproteins still displaying
non-native structures or partially assembled complexes are reglu-
cosylated by UGGT. By triggering the re-association of glycopro-
teins and CRT/CNX, UGGTs activity increases the solubility of
partially folded species and improves their chances to fold success-
fully [58]. UGGT is a unique enzyme of about 170kDa (1555 resi-
dues in humans) that mixes the activity of a glycosyltransferase
with the speciﬁcity of a classical chaperone [59]. UGGT KO in
mouse is embryonically lethal at E13 [60,61] and viability of S.
pombe lacking UGGT is only affected under extreme ER stress con-
ditions [62]. UGGT is an ER soluble protein that displays a
hydrophobic N-terminal signal peptide and a C-terminal
KDEL-like ER retention/retrieval signal. The catalytic activity of
the enzyme resides in the highly conserved C-terminal domain
(about 20% of the protein), that belongs to the glycosyltransferase
family 24. The N-terminal domain (80% of the protein) is believed
to be responsible for misfolded acceptor recognition. In most
organisms, monoglucosylated high mannose glycans can be
formed by two different processes, either by the ﬁrst GII cleavage
or by UGGT activity. For this reason the occurrence of the enzyme
was ﬁrst demonstrated in T. cruzi [63]: as this parasite transfers M9
to nascent glycoproteins, detection of G1M9 necessarily implied
the existence of a protein glucosylating activity. Early studies
clearly showed a marked preference of UGGT for misfolded glyco-
proteins, and the ﬁrst substrates employed in in vitro assays were
8 M urea-denatured bovine thyroglobulin, RNAse B or soybean
agglutinin (SBA) [64]. The original aim of using denatured sub-
strates was to improve the exposition of the N-glycans for increas-
ing substrate glucosylation but an unexpected fortunate collateral
consequence was the exposure of hydrophobic surface in the
acceptors. In vitro assays using well deﬁned substrates showed that
UGGT uses a bipartite signal, recognizing on one hand the N-glycan
innermost GlcNAc residue that is generally occluded in native con-
formations and exposed hydrophobic patches on high
mannose-bearing glycoproteins. This last recognition process
shows higher efﬁciency on advanced molten globule-like folding
intermediates and UGGT catalytic efﬁciency correlates with the
ANS-binding capacity of the acceptors (this drug associates prefer-
entially to proteins exposing hydrophobic patches) [65–67]. The
ability of UGGT can also be used to control the proper assembly
of oligomeric structures. For example, it is capable of glucosylating
well folded subunits of incompletely assembled SBA (a tetramer in
the native state), a likely consequence of the presence hydrophobic
patches exposed by this substrate [68]. In addition, glycopeptides
can also work as glucose acceptors, provided they are long enough
and that they have hydrophobic segments [69]. Surprisingly, UGGT
can also recognize hydrophobic non-proteinaceous epitopes
attached to high mannose glycans [70]. The distance required
between hydrophobic patches and the N-glycan is still a matter
of debate. While in some substrates it seems to be restricted to a
short range [71], in others it can be extended to a few nanometers
[72]. Recognition of substrate protein elements besides the accep-
tor glycan is not an exclusive feature of UGGT. For example,
UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine
phosphotransferase selectively initiates the formation of the man-
nose 6-P signal in lysosomal glycoproteins by recognizing not only
of a high mannose N-glycan but also a patch of positively charged
amino acid residues, while the UDP-Gal:glycoprotein hormone N-
acetylgalactosamyniltransferase selectively adds a GalNAc residue
to certain but not all secreted hormones. There are two homologsof the enzyme in mammals, UGGT1 and UGGT2 that display a
55% sequence identity (75% similarity). It was initially believed
that UGGT2 was inactive but more recent results showed that C.
elegans knock down of each protein displayed different phenotypes
[73] and that both proteins are active in a mouse hybridome [74].
Indeed, it has been recently shown in vitro that UGGT2 has a bona
ﬁde glucosyltransferase activity, with speciﬁcity similar to UGGT1
[60].
Even though it is expected that in vivo a wide range of glycopro-
teins are UGGT substrates, very few endogenous substrates have
been identiﬁed so far. Two known examples are lysosomal pro-
teases rich in disulﬁde bridges, prosaposin in mammals [75] and
cruzipain (CZ) in T. cruzi [76]. UGGT KO in T. cruzi precludes the
association of CZ and CRT and results in an enzyme impaired
oxidative maturation [30]. In those parasites most CZ molecules
are retained in the ER bound to BiP, with an important fraction
forming covalently bound aggregates. A similar situation was
observed for prosaposin in mouse uggt / cells. The exquisite
selectivity of UGGT can be exploited in subtle ways. For instance,
UGGT optimizes the loading to MHC class I (MHC-I) with high
afﬁnity peptides [77]. The peptide loading complex is composed
by tapasin, ERp57, the heavy chain of MHC-I, b2-microglobulin
and CRT. Tapasin forms a stable disulﬁde bridge with ERp57
domain a, while CRT stabilizes their association with MHC-I by
binding ERp57 and a conserved N-glycan attached to MCH-I.
Interestingly, UGGT preferentially reglucosylates the N-glycan of
those complexes containing suboptimal peptides, thus precluding
their exit from the ER.
UGGT activity is expected to facilitate binding of glycoproteins
to CRT/CNX, thus slowing their passage through the ER.
Nevertheless, experiments using mouse uggt / cells revealed a
more complex scenario [57]. Three type of glycoproteins appeared
in this system. On one hand there were glycoproteins whose tran-
sit was not affected or was accelerated upon UGGT deletion, the
latter being a logical consequence of a shorter interaction with
CRT/CNX. Surprisingly, some proteins showed a slower transit
through the ER. This observation pointed to a more active role of
UGGT in assisting the folding maturation of some glycoproteins.
In this respect, the selenium containing thioredoxin-like protein
Sep15 may modulate the activity of UGGT [78]. This protein dis-
plays an unusual CGU motif (where U stands for selenocysteine).
Sep15 associates with UGGT in a 1:1 complex with very high afﬁn-
ity (Kd 20 nM), thus retaining Sep15 in the ER [79]. Sep15 expres-
sion is enhanced upon ER stress [80], and it has been proposed that
may facilitate the oxidative maturation of some selected glycopro-
teins while being recognized by UGGT. Sep15 deﬁcient mice
develop early cataracts, probably due to a misfolding defect of lens
proteins [81]. In addition, in vitro assays showed that Sep15
increases the activity of UGGT1 and UGGT2, being this effect more
dramatic for the later protein [74]. This activation is independent
of any redox effect exerted by Sep15 on the substrates, pointing
to a modulation of the activity of the glucosyltransferases.
The balance between GII and UGGT activities is pivotal in deter-
mining glycoprotein binding to CRT/CNX. In vivo observations sug-
gest that as mannose residues are cleaved, UGGT activity
diminishes much less sharply than that of GII [19,82]. This would
ensure the retention of immature species in the ER. Nevertheless,
this may also negatively affect the passage of terminally misfolded
proteins to the ERAD machinery. Here lies one major puzzle, since
the QC and ERAD machinery should discriminate folding interme-
diates within a productive pathway from terminally misfolded pro-
teins. A mistake in any other way may have dangerous
consequences. Interestingly, even though UGGT delays the secre-
tion of immature glycoproteins, the enzyme does not affect the
processing of misfolded species by ERAD [83]. This implies that
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strates from the CRT/CNX cycle.
Recent structural studies on UGGT from the thermophilic fun-
gus Chaetomium thermophilum (1509 residues long, 51% similarity
with human UGGT1) suggest a plausible mechanism for substrate
recognition [84]. A bioinformatics analysis predicted that the
N-terminal portion of the protein contains three thioredoxin
(Trx)-like domains that lack a CXYC motif, followed by a b-rich
domain. This prediction was conﬁrmed after solving the structure
of the third Trx-like domain, showing a ﬁve-stranded b-sheet with
a b1–b3–b2–b4–b5 topology surrounded by six a-helices, very
similar to bacterial protein disulﬁde isomerase DsbA/C.
Interestingly, the third domain could be crystallized in two forms,
with and without a bound detergent molecule. A hydrophobic
patch composed by several conserved residues from strands
b2-b5 and helix a2 interacted alternatively with the detergent
molecule or with four hydrophobic residues of helix a6 (Phe820,
Phe825, Phe828 and Leu829). Homology modelling predicted sim-
ilar, or even larger, hydrophobic patches in the other two Trx-like
domains. Even though more biochemical and structural analysis
are needed, it can be speculated that this hydrophobic patch is
involved in the recognition of misfolded acceptors, while the plas-
ticity of helix a6 may serve to regulate its exposition in the absence
of substrates. The presence of three similar domains would provide
the ability to scan for structural defects at various distances from
the N-glycan. Given the high degree of similarity between
Chaetomium thermophilum and others UGGTs, an analogous
domain organization and structure is expected. In addition, these
ﬁndings suggest an evolutionary mechanism for the origin of this
enzyme, in which a portion of a PDI family protein may have fused
with a glycosyltransferase domain.
7. ERAD or a time for oblivion
Progressive loss of a1,2-mannose residues marks glycoproteins
for degradation. There are seven a1,2-mannosidades in the mam-
malian cell secretory pathway, all belonging to the glycosylhydro-
lase family 47: ER a1,2-mannosidase I (ER Man I), three ER
degradation-enhancing -mannosidase-like proteins (EDEM 1, 2
and 3) and three Golgi a1,2-mannosidases (Golgi Man IA, IB and
IC). The Golgi enzymes are responsible for trimming N-glycans
from M9-M8 to Man5GlcNAc2 (M5) of proteins continuing their
journey through the secretory pathway. This last trimming is the
ﬁrst step in the formation of hybrid- and complex-type glycans dis-
played by most mature glycoproteins. Subsequent trimming in the
Golgi until the core glycan (M3) is reached is performed by
a-mannosidase II, that cleaves the branching a1,3 and a1,6 bonds
of the B and C arms. Interestingly, some mature glycoproteins dis-
play high mannose structures. It is assumed that glycans located
distally to the Golgi inner membrane during secretion, may not
be fully accessible to the membrane-bound Golgi processing
mannosidases.
As mentioned above, the ERAD and QC machineries must dis-
criminate productive folding intermediates from irreparably mis-
folded species, a particularly difﬁcult task for proteins with slow
folding pathways. Mannose trimming in the ER is carried out by
ER Man I and the EDEMs, which are not particularly efﬁcient pro-
teins. For this reason, even though the three EDEMs display all
the residues needed for catalysis and can bind the inhibitor kifu-
nensin, their mannosidase activity was difﬁcult to detect. It is
believed that the low efﬁciency of those enzymes enables the
occurrence of a mechanism known as ‘‘mannose timer’’, that
allows the conformational maturation of slow folding proteins
(see below). In basal situations ER Man I is mainly located in
ER-derived quality control vesicles (QCVs) and upon ER-stress itmigrates to ER sites harboring the main elements of the QC
(ERQCs, see below) [85–88]. This initial physical separation would
protect folding glycoproteins from ER Man I. Upon ER stress, mis-
folded glycoproteins would migrate to the ERQCs where they
encounter a high concentration of ER Man I, thus sharply increas-
ing the mannose trimming pace. In addition, other important com-
ponents of the ERAD and QC systems such as CRT, CNX, EDEM1,
OS-9 and XTP3-B also localize to the ERQC. Probably, CRT and
CNX may commute their client proteins between the ER and the
ERQCs. ER Man I and EDEM1 are single-pass type II membrane pro-
teins, while EDEM2 and EDEM3 are soluble proteins. EDEM1 has
ﬁve N-glycosylation sequons, where the most C-terminal site is
partially occupied. In addition, EDEM1 signal peptide is processed
very slowly, thus rendering a mix of soluble and membrane bound
species [89]. Membrane-bound EDEM1 associates with the ERAD
scaffold protein SEL1L, while the soluble form binds to ERdj5
[90], a unique J-domain containing PDI with a strong reductase
activity. This complex is reminiscent of the CRT/CNX-ERp57 com-
plexes. ERdj5 reduces the disulﬁde bridges of glycosylated ERAD
substrates, and handles them to BiP through its J-domain in an
ATP-dependent manner; BiP in turn delivers the substrates to the
ERAD machinery [91]. Non-glycoprotein ERAD substrates may be
delivered by BiP to ERdj5, and after reduction of their disulﬁde
bridges they are also transferred by BiP to the SEL1L-containing
complex [92]. Interestingly, glycoproteins use this last pathway
upon inhibition of glucose trimming, meaning that under stress
condition the ERAD pathways for glycosylated and
non-glycosylated substrates can be interchangeable.
The exact contribution of each a1,2-mannosidade to the trim-
ming process is still under investigation. It was originally believed
that generation of the isomer M8B, which lacks the more external
mannose residue of B arm (residue i, Fig. 1B), was the signal for
degradation. It was recently shown that EDEM2 is the main
responsible for this step, with some contribution of ER Man I.
Nevertheless, M8B is also displayed by properly folded proteins
that reach the Golgi. It is accepted now that further mannose trim-
ming is needed for diversion to ERAD and that most ERAD sub-
strates end displaying Man6GlcNAc2 (M6) and M5 [93].
Apparently, EDEM 1 and 3, and to some extent ER Man I, are in
charge of the subsequent loss of mannose that generate M7BC
and M7AB isomers (M7s lacking residues i and k or g and i, respec-
tively, Fig. 1B) [94]. Those enzymes are also believed to be respon-
sible for the acquisition of the ﬁnal M6 and M5 glycoforms. A
crucial event is the cleavage the outer a1,2-mannose of A arm
(residue g, Fig. 1B), the acceptor site for UGGT activity, since this
cleavage deﬁnitively extracts the glycoprotein from the CRT/CNX
cycle. Removal of residue g may be performed also by a cis Golgi
endomannosidase (EM) that yields the disaccharide Glc1Man1
from G1M9 or G1M8B. As mentioned above, forcing the occurrence
of a monoglucosylated glycoform does not seem to affect the
degradation kinetics of some glycoproteins [83]. In this sense, ER
Man I can use glucosylated substrates, thus indicating that it
may be operative while they are still in the CRT/CNX cycle [95].
A very important step is the uncovering of the a1,6-mannose in
arm C (residue j, Fig. 1B) [78,79]. This residue is the main epitope
recognized by lectins OS-9 [96,97] and XTP3-B [98,99], which
through their MRH domains (one in OS-9 and two in XTP3-B)
escort the substrate to the dislocon and the ubiquitination machin-
ery of the ERAD. Interestingly, it has been found that XTP3-B may
have a stabilizing effect on some misfolded substrates, probably by
delaying its premature degradation [100]. Both mannose removal
steps, conversion of M9 to M8B and of this last glycan to M7BC
are slow processes in mammalians cells when compared to the
deglucosylation reactions. This fact affords two checkpoints ensur-
ing that only terminally misfolded glycoproteins, and not folding
intermediates, are derived to proteasomal degradation after a
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sent in the budding yeast, in which an ER a-mannosidase I and
only one EDEM-like protein called Htm1p are present. The former
transforms M9 to M8B very rapidly in practically all glycoproteins,
whereas the latter converts M8B to M7BC in a slow fashion, thus
affording only one checkpoint for the exclusive degradation of ter-
minally misfolded glycoproteins. Htm1p was found to be forming a
complex with protein disulﬁde isomerase. The oxidoreductase
enhanced the mannosidase activity of Htm1p and participated in
the recognition of ERAD substrates. In the ﬁssion yeast S. pombe
there are, similarly to S. cerevisiae only one ER a-mannosidase
and Htm1p-like proteins, but in this case both demannosylation
reactions are slow processes [101].
Retrotranslocation of misfolded glycoproteins from the ER
lumen to the cytosol to be eventually degraded by proteasomes
ultimately depends of protein complexes some of whose compo-
nents are integral ER membrane proteins [102]. Depending on the
location of the misfolded domain, proteins are delivered to protea-
somal degradation through different complexes. Thus, ER mem-
brane proteins with folding defects in the cytosolic portion of the
molecule (ERAD-C) are extracted from the ER membrane by the
so called Doa10 complex, whereas those in which the folding defect
is present in the lumenal (ERAD-L) or membrane (ERAD-M) por-
tions of the molecules utilize the Hrd1 complex. Both Doa10p and
Hrd1p are integral membrane proteins showing E3 ligase activity
in their cytosolic portions. In addition, other proteins both lumenal
and cytosolic, form part of the complexes. Some of them are chap-
erones, others display E2 ubiquitin-conjugating activity or partici-
pate in misfolded protein recognition. For instance, glycoproteins
exposing a(1,6)-linked mannosyl units bound to OS9 are driven
to degradation only if present in unstructured polypeptides, a fea-
ture recognized by Hrd3p, a protein found in the Hrd1 complex.
Finally, there are protein components common to both complexes,
as for instance p97 in mammals, responsible for the membrane
extraction of misfolded proteins in an ATP-dependent manner. It
should be mentioned that the pore by which ERAD-L substrates
are actually transported to the cytosol has not been unequivocally
identiﬁed yet but it has been established that to be able to be
translocated to the cytosol, misfolded lumenal proteins must be
previously unfolded in the ER lumen, a process involving conven-
tional chaperones and protein disulﬁde isomerases.
N-glycans are removed from the protein moieties prior to pro-
teasomal degradation. It appears that a cytoplasmic
peptide:N-glycanase (PNGase) plays an important role in both
removing the glycan and constructing an efﬁcient predegradation
complex. PNGase recognizes onlymisfolded or denatured glycopro-
teins and the enzyme is bound to the proteasome by subunits S4
and HR23B as a complex with cytoplasmic protein Cdc48, a compo-
nent of both ERAD complexes [103,104]. Degradation of the
released glycan occurs in two stages. First, partial cleavage occurs
between the chitobiose core via a cytoplasmic endo-b-N-acetylglu
cosaminidase or possibly a neutral-pH cytoplasmic chitobiase. A
cytoplasmic a-mannosidase cleaves up to four mannose residues
to generate Man5GlcNAc (residues b, c, d, e, f and g, Fig. 1B) [105].
This glycan is then taken into the lysosome for ﬁnal degradation
to monosaccharides via an ATP-dependent lysosomal membrane
transporter [106].
8. Perspectives
Over the last years the ﬁeld of protein folding and degradation
in the ER has become more complex and a myriad of new players
have been discovered. The ER has revealed as a very rich compart-
ment, with a dynamic spatial organization that responds to the dif-
ferent demands of the cell. Its proper function relies not only on
the molecular speciﬁcities of its components, but also on theirtimely and spatial coordination. Subtle changes in calcium concen-
tration, pH and membrane composition among the different sub-
compartments of the early secretory pathway may regulate the
activity of various cargo receptors. The fact that many components
of the glycoprotein recognition and processing systems are sensi-
tive toward the folding status of their ligands and substrates could
explain the exquisite discrimination ability of the ERAD.
Interestingly, during evolution a limited repertoire of structural
domains (Trx, MRH, J, etc) was combined to create those marvelous
systems. How the ER responds to widely different requirements
and how coordination between the QC and ERAD machineries is
achieved is still under active research. A detailed comprehension
of these issues could provide new therapeutic strategies to treat
a wide spectrum of human diseases, mainly the so called ‘‘confor-
mational diseases’’, that is diseases in which key proteins are
unable to properly fold and are initially retained in the ER and
eventually sent to degradation by the ERAD machinery.
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